Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
European Journal of Medicinal Chemistry
|
November 6, 2007
Synthesis and biological activity of imidazopyridine anticoccidial agents: Part II
Andrew Scribner, Richard Dennis, Shuliang Lee, et al.
Beilstein Journal of Organic Chemistry
|
February 10, 2021
Novel library synthesis of 3,4-disubstituted pyridin-2(1<i>H</i>)-ones via cleavage of pyridine-2-oxy-7-azabenzotriazole ethers under ionic hydrogenation conditions at room temperature
Romain Pierre, Anne Brethon, Sylvain A Jacques, et al.
Journal of Medicinal Chemistry
|
June 4, 2016
Discovery of Novel 3-Quinoline Carboxamides as Potent, Selective, and Orally Bioavailable Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase
Sébastien L Degorce, Bernard Barlaam, Elaine Cadogan, et al.
Journal of Medicinal Chemistry
|
July 4, 2018
Correction to Discovery of Novel 3-Quinoline Carboxamides as Potent, Selective, and Orally Bioavailable Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase
Sébastien L Degorce, Bernard Barlaam, Elaine Cadogan, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 1, 2018
Structure-based design of Trifarotene (CD5789), a potent and selective RARγ agonist for the treatment of acne
Etienne Thoreau, Jean-Marie Arlabosse, Claire Bouix-Peter, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 21, 2017
Discovery of a novel aminopyrazine series as selective PI3Kα inhibitors
Bernard Barlaam, Sabina Cosulich, Martina Fitzek, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 6, 2016
Discovery of phenoxyindazoles and phenylthioindazoles as RORγ inverse agonists
Gilles Ouvry, Claire Bouix-Peter, Fabrice Ciesielski, et al.
ACS Medicinal Chemistry Letters
|
November 22, 2019
Impact of Minor Structural Modifications on Properties of a Series of mTOR Inhibitors
Gilles Ouvry, Laurence Clary, Loïc Tomas, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 18, 2015
Discovery of 1-(4-(5-(5-amino-6-(5-tert-butyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl)-1-ethyl-1,2,4-triazol-3-yl)piperidin-1-yl)-3-hydroxypropan-1-one (AZD8835): A potent and selective inhibitor of PI3Kα and PI3Kδ for the treatment of cancers
Bernard Barlaam, Sabina Cosulich, Bénédicte Delouvrié, et al.
Journal of Medicinal Chemistry
|
August 17, 2016
Optimization of a Series of Bivalent Triazolopyridazine Based Bromodomain and Extraterminal Inhibitors: The Discovery of (3R)-4-[2-[4-[1-(3-Methoxy-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)-4-piperidyl]phenoxy]ethyl]-1,3-dimethyl-piperazin-2-one (AZD5153)
Robert H Bradbury, Rowena Callis, Gregory R Carr, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
European Journal of Medicinal Chemistry
|
November 6, 2007
Synthesis and biological activity of imidazopyridine anticoccidial agents: Part II
Andrew Scribner, Richard Dennis, Shuliang Lee, et al.
Beilstein Journal of Organic Chemistry
|
February 10, 2021
Novel library synthesis of 3,4-disubstituted pyridin-2(1<i>H</i>)-ones via cleavage of pyridine-2-oxy-7-azabenzotriazole ethers under ionic hydrogenation conditions at room temperature
Romain Pierre, Anne Brethon, Sylvain A Jacques, et al.
Journal of Medicinal Chemistry
|
June 4, 2016
Discovery of Novel 3-Quinoline Carboxamides as Potent, Selective, and Orally Bioavailable Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase
Sébastien L Degorce, Bernard Barlaam, Elaine Cadogan, et al.
Journal of Medicinal Chemistry
|
July 4, 2018
Correction to Discovery of Novel 3-Quinoline Carboxamides as Potent, Selective, and Orally Bioavailable Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase
Sébastien L Degorce, Bernard Barlaam, Elaine Cadogan, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 1, 2018
Structure-based design of Trifarotene (CD5789), a potent and selective RARγ agonist for the treatment of acne
Etienne Thoreau, Jean-Marie Arlabosse, Claire Bouix-Peter, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 21, 2017
Discovery of a novel aminopyrazine series as selective PI3Kα inhibitors
Bernard Barlaam, Sabina Cosulich, Martina Fitzek, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 6, 2016
Discovery of phenoxyindazoles and phenylthioindazoles as RORγ inverse agonists
Gilles Ouvry, Claire Bouix-Peter, Fabrice Ciesielski, et al.
ACS Medicinal Chemistry Letters
|
November 22, 2019
Impact of Minor Structural Modifications on Properties of a Series of mTOR Inhibitors
Gilles Ouvry, Laurence Clary, Loïc Tomas, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 18, 2015
Discovery of 1-(4-(5-(5-amino-6-(5-tert-butyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl)-1-ethyl-1,2,4-triazol-3-yl)piperidin-1-yl)-3-hydroxypropan-1-one (AZD8835): A potent and selective inhibitor of PI3Kα and PI3Kδ for the treatment of cancers
Bernard Barlaam, Sabina Cosulich, Bénédicte Delouvrié, et al.
Journal of Medicinal Chemistry
|
August 17, 2016
Optimization of a Series of Bivalent Triazolopyridazine Based Bromodomain and Extraterminal Inhibitors: The Discovery of (3R)-4-[2-[4-[1-(3-Methoxy-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)-4-piperidyl]phenoxy]ethyl]-1,3-dimethyl-piperazin-2-one (AZD5153)
Robert H Bradbury, Rowena Callis, Gregory R Carr, et al.
Page
of 3